[an error occurred while processing this directive] | [an error occurred while processing this directive]
Feasibility of placing a dose constraint to peritoneal space instead of bowel loop in protection of the small intestine during intensity-modulated radiotherapy for rectal cancer
Qian Jianjun,Sun Yanze,Yang Yongqiang,Chen Liesong,Tian Ye
Department of Radiation Oncology,Second Affiliated Hospital of Soochow University;Institute of Radiotherapy and Oncology,Soochow University;Suzhou Key Laboratory for Radiation Oncology,Suzhou 215004,China
AbstractObjective To compare the dose volume and normal tissue complication probability (NTCP) of small intestine between intensity-modulated radiotherapy (IMRT) with dose constraints to the peritoneal space (PS) and the bowel loop (BL) in the treatment of rectal cancer, and to investigate the feasibility of placing a dose constraint to the PS instead of the BL in protection of the small intestine. Methods A total of 24 patients with rectal cancer undergoing postoperative adjuvant radiotherapy were enrolled as subjects. In the 24 patients, 12 were treated in supine position and 12 in prone position. The weekly computed tomography (CT) scans from pre-treatment to weeks 1-4 of treatment were defined as Plan, 1 W, 2 W, 3 W, and 4 W. Contours of PS and BL were delineated on all CT images. Based on the Plan CT images, two IMRT plans, PPS and PBL, were designed with dose constraints to the PS and BL, respectively. The method was applied to 1-4 W CT images. For each CT scan, the dose volume and NTCP of the small intestine were evaluated in PPS and PBL. Results A total of 109 sets of CT images were acquired from 24 patients, and 218 plans were designed and copied. The median volume of the PS and BL was 1339.28 and 250.27 cm3, respectively. For the Plan CT scans, V15 values of the PS in PPS plan and the BL in PBL plan were 918.96 and 199.57 cm3, respectively. For all CT scans, the dose volume of the small intestine in PPS, in most cases, was lower than that in PBL, while V15 values in PPS and PBL were 170.07 and 178.58 cm3(P=0.000). The dose volume of the small intestine was correlated with V15(P=0.000). PPS had significantly lower NTCP of chronic and acute adverse reactions than PBL (2.80% vs. 3.00%, P=0.018;57.32% vs. 58.64%, P=0.000). In patients with prone and supine treatment positions, most of the dose volume and NTCP of the small intestine in PPS were significantly lower than those in PBL (P<0.05 for V10, V15, V30, and NTCP of acute adverse reactions). Conclusions It is feasible to place a dose constraint to the PS instead of the BL for protection of the small intestine during IMRT for rectal cancer. V15<830 cm3 can be referred to as the objective function of dose restraint.
Qian Jianjun,Sun Yanze,Yang Yongqiang et al. Feasibility of placing a dose constraint to peritoneal space instead of bowel loop in protection of the small intestine during intensity-modulated radiotherapy for rectal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(2): 165-170.
Qian Jianjun,Sun Yanze,Yang Yongqiang et al. Feasibility of placing a dose constraint to peritoneal space instead of bowel loop in protection of the small intestine during intensity-modulated radiotherapy for rectal cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(2): 165-170.
[1] Brndengen M,Tveit KM,Berglund,et al. Randomized phase Ⅲ study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer[J].J Clin Oncol,2008,26(22):3687-3694.DOI:10.1200/JCO.2007.15.3858. [2] Bosset JF,Collette L,Calais G,et al. Chemotherapy with preoperative radiotherapy in rectal cancer[J].N Engl J Med,2006,355(11):1114-1123.DOI:10.1056/NEJMoa060829. [3] Braendengen M,Tveit KM,Berglund A,et al. Randomized phase Ⅲ study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer[J].J Clin Oncol,2008,26(22):3687-3694.DOI:10.1200/JCO.2007.15.3858. [4] Bruheim K,Guren MG,Skovlund E,et al. Late side effects and quality of life after radiotherapy for rectal cancer[J].Int J Radiat Oncol Biol Phys,2010,76(4):1005-1011.DOI:10.1016/j.ijrobp.2009.03.010. [5] Brndengen M,Tveit KM,Hjermstad MJ,et al. Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long term results from a phase Ⅲ study[J].Eur J Cancer,2012,48(6):813-819.DOI:10.1016/j.ejca.2011.06.035. [6] Gandhi AK,Sharma DN,Rath GK,et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma:a prospective randomized study[J].Int J Radiat Oncol Biol Phys,2013,87(3):542-548.DOI:10.1016/j.ijrobp.2013.06.2059. [7] Gunnlaugsson A,Kjellén E,Nilsson P,et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer[J].Acta Oncol,2007,46(7):937-944.DOI:10.1080/02841860701317873. [8] Robertson JM,Lockman D,Yan D,et al. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer[J].Int J Radiat Oncol Biol Phys,2008,70(2):413-418.DOI:10.1016/j.ijrobp.2007.06.066. [9] Marks LB,Yorke ED,Jackson A,et al. Use of normal tissue complication probability models in the clinic[J].Int J Radiat Oncol Biol Phys,2010,76(3):S10-S19.DOI:10.1016/j.ijrobp.2009.07.1754. [10] Gay HA,Barthold HJ,O’Meara E,et al. Pelvic normal tissue contouring guidelines for radiation therapy:a radiation therapy oncology group consensus panel atlas[J].Int J Radiat Oncol Biol Phys,2012,83(3):e353-e362.DOI:10.1016/j.ijrobp.2012.01.023. [11] Banerjee R,Chakraborty S,Nygren I,et al. Small bowel dose parameters predicting grade ≥3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation:an independent validation study comparing peritoneal space versus small bowel loop contouring techniques[J].Int J Radiat Oncol Biol Phys,2012,85(5):1225-1231.DOI:10.1016/j.ijrobp.2012.09.036. [12] Myerson RJ,Garofalo MC,El Naqa I,et al. Elective clinical target volumes for conformal therapy in anorectal cancer:a radiation therapy oncology group consensus panel contouring atlas[J].Int J Radiat Oncol Biol Phys,2009,74(3):824-830.DOI:10.1016/j.ijrobp.2008.08.070. [13] Reyngold M,Niland J,Ter Veer A,et al. Neoadjuvant radiotherapy use in locally advanced rectal cancer at Ncm3N member institutions[J].J Natl Compr Canc Netw,2014,12(2):235-243. [14] Webb S,Nahum AE.A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density[J].Phys Med Biol,1993,38(6):653-666. [15] Burman C,Kutcher GJ,Emami B,et al. Fitting of normal tissue tolerance data to an analytic function[J].Int J Radiat Oncol Biol Phys,1991,21(1):123-135. [16] Lyman JT,Wolbarst AB.Optimization of radiation therapy,Ⅲ:a method of assessing complication probabilities from dose-volume histograms[J].Int J Radiat Oncol Biol Phys,1987,13(1):103-109.DOI:10.1016/0360-3016(87)90266-5. [17] Cella L,Ciscognetti N,Martin G,et al. Preoperative radiation treatment for rectal cancer:comparison of target coverage and small bowel NTCP in conventional vs.3D-conformal planning[J].Med Dosim,2009,34(1):75-81.DOI:10.1016/j.meddos.2008.04.001. [18] Tho LM,Glegg M,Paterson J,et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer:investigating dose-volume relationships and role for inverse planning[J].Int J Radiat Oncol Biol Phys,2006,66(2):505-513.DOI:10.1016/j.ijrobp.2006.05.005. [19] Chi A,Nguyen NP,Xu J,et al. Correlation of three different approaches of small bowel delineation and acute lower gastrointestinal toxicity in adjuvant pelvic intensity-modulated radiation therapy for endometrial cancer[J].Technol Cancer Res Treat,2012,11(4):353-359. [20] 孙彦泽,周钢,钱建军,等.宫颈癌放疗计划中小肠3种勾画方法比较[J].中华放射肿瘤学杂志,2016,25(1):67-70.DOI:10.3760/cma.j.issn.1004-4221.2016.01.017. Sun YZ,Zhou G,Qian JJ,et al. The comparison of three bowel delineation strategies in the radiation therapy of cervical cancer[J].Chin J Radiat Oncol,2016,25(1):67-70.DOI:10.3760/cma.j.issn.1004-4221.2016.01.017. [21] Robertson JM,Shn M,Yan D.Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model[J].Int J Radiat Oncol Biol Phys,2010,77(1):66-72.DOI:10.1016/j.ijrobp.2009.04.048. [22] Kavanagh BD,Pan cm3,Dawson LA,et al. Radiation dose-volume effects in the stomach and small bowel[J].Int J Radiat Oncol Biol Phys,2010,76(3S):S101-S107.10.1016/j.ijrobp.2009.05.071. [23] 姚泰.生理学(全国高等学校教材,供8年制及7年制临床医学等专业用)[M].北京:人民卫生出版社,2011:284-287.Yao T.Physiology (National University teaching materials for 8 years and clinical medicine, such as the use of 7 years)[M].Beijing:People′s Medical Publishing House,2011:284-287. [24] Kvinnsland Y,Muren LP.The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer[J].Radiother Oncol,2005,76(1):43-47.DOI:10.1016/j.radonc.2005.06.007.
2017, Vol. 26 
